Substance / Medication

Colchicine

Overview

Active Ingredient
colchicine
RxNorm CUI
2683

Indications

Colchicine capsules are indicated for prophylaxis of gout flares in adults. Limitations of Use: The safety and effectiveness of colchicine capsules for acute treatment of gout flares during prophylaxis has not been studied. Colchicine capsules are not an analgesic medication and should not be used to treat pain from other causes.

Labeler: Micro Labs LimitedUpdated: 2026-02-17T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

[see Drug Interactions (7) ]. Patients with renal or hepatic impairment should not be given colchicine capsules with drugs that inhibit both P-glycoprotein and CYP3A4 inhibitorsCombining these dual inhibitors with colchicine in patients with renal or hepatic impairment has resulted in life-threateni

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

25 trials linked to this intervention

25
Total Trials
7
Recruiting
13
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Colchicine in acute coronary syndromes: a systematic review and meta-analysis of randomised controlled trials.
Huntermann Ramon, Peres de Oliveira Juan, Barbosa Lucas M et al. · Heart · 2026
PMID: 40379469Meta-Analysis
Colchicine prophylaxis in pediatric PFAPA: a systematic review.
Dipasquale Rosario Francesco, Sinopoli Paola, Mendicino Alessia et al. · Eur J Pediatr · 2026
PMID: 41495479Meta-Analysis
Colchicine for secondary prevention in patients with acute coronary syndrome: A systematic review and meta-analysis.
Shaikh Safia, Hamza Mohammad, Neppala Sivaram et al. · Int J Cardiol · 2025
PMID: 39923944Meta-Analysis
Colchicine for the primary prevention of cardiovascular events.
Martí-Carvajal Arturo J, Gemmato-Valecillos Mario A, Monge Martín Diana et al. · Cochrane Database Syst Rev · 2025
PMID: 39927511Meta-AnalysisFull text (PMC)
Magnitude of effect of low dose colchicine, a newly food and drug administration approved treatment for stroke prevention.
Escalera Erica, Saver Jeffrey L · J Stroke Cerebrovasc Dis · 2025
PMID: 39667442Meta-Analysis
The effect of colchicine on myocardial infarction: An updated systematic review and meta-analysis of randomized controlled trials.
Younas Ayesha, Awan Zainab, Khan Tehreem et al. · Curr Probl Cardiol · 2025
PMID: 39393620Meta-Analysis
Low-dose colchicine for stroke prevention: A systematic overview of systematic reviews and meta-analyses.
Noll Giovani, Borelli Wyllians Vendramini, Mantovani Gabriel Paulo et al. · J Stroke Cerebrovasc Dis · 2025
PMID: 39653300Meta-Analysis
Efficacy and Safety of Colchicine in Pediatric Pericarditis: A Systematic Review and Future Directions.
Alsabri Mohammed, Elsayed Sarah Makram, Elsnhory Ahmed Bostamy et al. · Pediatr Cardiol · 2025
PMID: 39080042Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Colchicine (substance)
SNOMED CT
387413002
UMLS CUI
C0009262
RxNorm CUI
2683
Labeler
Micro Labs Limited

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
25
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.